Screenshot 2024-12-18 at 6.00.43 PM.png

ACCELERATING THE TRANSITION TO A MORE SUSTAINABLE AND RESILIENT FUTURE

CROSS RIVER INFRASTRUCTURE PARTNERS


Cross River Infrastructure Partners develops critical infrastructure across energy, digital, and healthcare sectors.  

Our mission is to design and deliver transformative projects that align advanced energy systems, sovereign digital capacity, and essential medical technologies to build more sustainable, resilient communities and global supply chains.

OUR FOCUS


Cross River is developing SMR-based advanced nuclear power projects for data center applications, leveraging our significant new-build and large-project nuclear and investment industry experience, supported by a network of collaborative strategic partners with deep, long-standing expertise in the industry. 

We believe that advanced nuclear power generation represents the best pathway to meet soaring global demand for clean, baseload energy. By harnessing the potential of advanced nuclear Small Modular Reactor (SMR) behind-the-meter energy parks, we not only reduce carbon footprints but also foster economic growth, improve energy security, and create new opportunities for the communities we serve.

 Our energy developments also include hydrogen electrolysis facilities that will be powered by new nuclear and will be used both as a clean fuel alternative as well as a battery alternative.

In 2024, Cross River Infrastructure Partners (CRIP) expanded its energy-development work to launch a dedicated data-center development platform focused on creating world-class digital-infrastructure campuses across North America. These campuses offer both powered-land and powered-shell alternatives, giving data-center operators flexible pathways to scale rapidly with reliable, high-density power supported by CRIP’s advanced nuclear-energy development pipeline.

CRIP is developing two flagship campus locations and is currently evaluating a third, each selected for proximity to major transmission infrastructure, low-latency fiber routes, and supportive regulatory environments. CRIP is also collaborating with a local data-center operator to develop one or more facilities on these sites.

As Artificial Intelligence (AI) accelerates demand for digital capacity, power availability has become the defining constraint. Data-center electricity consumption in the U.S. is projected to rise from ~3% of total load in 2023 to 9–12% by 2030—on top of increasing electrification across transportation, heating, and industry.

CRIP’s dual expertise in energy infrastructure and nuclear development positions the platform uniquely to meet this challenge. By pairing near-term, grid-integrated power solutions with a future pathway to behind-the-meter nuclear generation, CRIP designs data-center campuses that work with the grid, not against it—leveraging existing assets, reducing system strain, and supporting long-term rate-payer affordability while enabling sustained digital and AI growth.

Cross River is advancing critical medical-radioisotope production as an integral pillar of our nuclear development activities – helping meet urgent global healthcare needs while creating high-value economic and social benefit.

Medical isotopes enable essential cancer and cardiac diagnostics, as well as next-generation targeted cancer therapeutics. Yet the global supply chain for key isotopes such as Molybdenum-99 (Mo-99) and Lutetium-177 (Lu-177) is deeply fragile, facing chronic shortages and repeated disruptions. Production today relies on a small number of aging, offshore research reactors that were never designed for clinical-scale manufacturing and are increasingly at risk of unplanned outages.

Cross River, together with our partners, is developing modern, purpose-built infrastructure to stabilize and expand this supply. By integrating advanced nuclear systems with on-site processing capabilities, we aim to strengthen North American access to diagnostic and therapeutic isotopes, reducing dependence on vulnerable international sources, and support the growing pipeline of life-extending radiopharmaceuticals.

Our work in this sector positions New Brunswick as a future hub for high-value medical-isotope production – improving patient access, enabling innovation in precision medicine, and contributing meaningfully to healthcare resilience across Canada and global markets.

Our Team


  • Andrew Wilder

    Andrew Wilder

    Chief Executive Officer

    +
  • Rishi Jain

    Rishi Jain

    Managing Director, Business Development

    +
  • David Robbins

    David Robbins

    General Counsel

    +
  • Tim Frazier

    Tim Frazier

    Senior Operating Partner, Nuclear: Technology & Government Relations

    +
  • Kevin Andrade

    Kevin Andrade

    Senior Operating Partner, Clean Fuels

    +
  • Scott Jarnagin

    Scott Jarnagin

    Senior Operating Partner, Data Centers

    +
  • Scott Metcalfe

    Scott Metcalfe

    Senior Operating Partner, Data Centers

    +
  • Claude Luster

    Claude Luster

    Senior Operating Partner, Biomass Conversion

    +
  • Ian McComiskie

    Ian McComiskie

    Operating Partner, Project Finance

    +
  • Steve Kane

    Steve Kane

    Operating Partner, Operations

    +
Minimalistic logomark for Cross River LLC representing a bridge